GlassScriptPhysician profile
Craig George Flinders
NPI 1760403893
$12,699.92
in general payments reported to CMS, 2019-2025
12 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.94 · 2020: $1,548 · 2021: $478 · 2022: $598 · 2023: $7,005 · 2024: $1,551 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,300 · Travel and Lodging: $2,974 · Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,300.00 |
| Travel and Lodging | $2,973.66 |
| Food and Beverage | $1,716.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,462.26 | 2019-2025 | Superion Indirect Decompression System, Intracept, Intracept Rf Probe |
| Medtronic, INC. | $481.97 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Grt US Holding, INC. | $201.00 | 2022 | |
| Vertos Medical, INC. | $167.71 | 2021-2024 | Mild Device Kit |
| Abbott Laboratories | $101.00 | 2019-2021 | |
| Stimwave Technologies Incorporated | $68.49 | 2022 | |
| Relievant Medsystems, INC. | $56.02 | 2021 | |
| Novo Nordisk INC | $50.25 | 2022 | |
| Stryker Corporation | $40.62 | 2024 | Mild Device Kit |
| Pfizer INC. | $36.88 | 2019 | |
| Si-Bone, INC. | $18.35 | 2024 | |
| Piramal Critical Care | $15.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Flinders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.